11 March 2016 - Communicable Disease Control Branch
A TGA registered BCG vaccine has not been available for use in Australia since 31 December 2015. This relates to a global shortage over the past 3 years from manufacturing delays and at the same time increased demand. In 2015 WHO reported that 180 million doses were needed to meet UNICEF demands but only 107 million doses were made available from manufacturers. As such, at the global level BCG vaccine is being allocated on a priority basis to high TB burden countries.
Presently it is not certain when new stock of a TGA registered BCG vaccine product will be available in Australia.
16 February 2016 - Communicable Disease Control Branch
As of 18 February 2016, rheumatic fever, rheumatic heart disease, Hendra virus infection,Vibrio parahaemolyticus infection, chancroid, and poliovirus infection (previously notifiable as poliomyelitis) will be notifiable diseases in South Australia under the South Australian Public Health Act 2011.